Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jacr.2023.08.044 | DOI Listing |
Publication Analysis
Top Keywords
reply
4
reply
1
Similar Publications
Editorial: High Baseline ALT Level Confers Risk of Hepatic Adverse Events During Immune Checkpoint Inhibitors Treatment: A Call for Caution-Authors' Reply.
Aliment Pharmacol Ther
January 2025
Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Reply to Íris Batista's Letter to the Editor about "Exploring the Correlation between Health Literacy and Knowledge of Cervical Cancer and Radiotherapy among Japanese Women: A Web-based Survey".
J Cancer Educ
January 2025
Department of Comprehensive Radiation Oncology, The University of Tokyo, 7-3-1 Hongo Bunkyo-Ku, Tokyo, 113-0033, Japan.
Letter: Identifying the Best Model for Predicting Post-SVR HCC-Authors' Reply.
Aliment Pharmacol Ther
January 2025
Egyptian Liver Research Institute and Hospital (ELRIAH), Mansoura, Egypt.
Reply to: "Two Families with ANO10-Related Spinocerebellar Ataxia with Novel Exon Deletions: A First Report from India".
Mov Disord
January 2025
Clinic for Neurology, University Clinical Center of Serbia, Belgrade, Serbia.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!